Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
The British Journal of Radiology|November 23, 2018
An orthotopic non-small cell lung cancer model for image-guided small animal radiotherapy platformsVenus Sosa Iglesias, Stefan J van Hoof, Ana Vaniqui, et al.
Cancers|May 28, 2020
Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation TracerSebastian Sanduleanu, Alexander M A van der Wiel, Relinde I Y Lieverse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET UptakeDaniela Trani, Ala Yaromina, Ludwig Dubois, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2016
Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumoursChristina Jentsch, Ralf Bergmann, Kerstin Brüchner, et al.
Journal of Translational Medicine|August 26, 2023
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenograftsLydia Koi, Verena Bitto, Corina Weise, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2015
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsivenessApostolos Menegakis, Chiara De Colle, Ala Yaromina, et al.
Oncoimmunology|April 11, 2018
The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responsesNicolle H Rekers, Veronica Olivo Pimentel, Ala Yaromina, et al.
Oncotarget|June 22, 2018
Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cellsJustina Kazokaitė, Raymon Niemans, Virginija Dudutienė, et al.
NPJ Precision Oncology|February 10, 2026
Predicting homologous recombination deficiency and treatment responses using a computed tomography-based foundation model: a preclinical studySheng Kuang, Lesley Schuitmaker, Min Wu, et al.
European Journal of Medicinal Chemistry|November 9, 2016
New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugsSimon J A van Kuijk, Nanda Kumar Parvathaneni, Raymon Niemans, et al.
Pageof 9